NLG919
98%
- Product Code: 61525
CAS:
1402836-58-1
| Molecular Weight: | 282.38 g./mol | Molecular Formula: | C₁₈H₂₂N₂O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD26142661 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
NLG919 is primarily studied for its potential in cancer immunotherapy. It functions as an inhibitor of the enzyme indoleamine 2,3-dioxygenase 1 (IDO1), which plays a role in suppressing the immune system within the tumor microenvironment. By blocking IDO1, NLG919 helps to enhance the body's immune response against cancer cells, making it a promising candidate for combination therapies with other immunotherapeutic agents like checkpoint inhibitors. Its application is particularly focused on improving the efficacy of treatments for various types of cancers, including melanoma, breast cancer, and lung cancer. Research is ongoing to explore its full potential in clinical settings.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Yellow to Tan Powder, Crystals or Chunks |
| PURITY | 97.5 100% |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿1,460.00 |
+
-
|
| 0.050 | 10-20 days | ฿4,680.00 |
+
-
|
| 0.250 | 10-20 days | ฿17,800.00 |
+
-
|
NLG919
NLG919 is primarily studied for its potential in cancer immunotherapy. It functions as an inhibitor of the enzyme indoleamine 2,3-dioxygenase 1 (IDO1), which plays a role in suppressing the immune system within the tumor microenvironment. By blocking IDO1, NLG919 helps to enhance the body's immune response against cancer cells, making it a promising candidate for combination therapies with other immunotherapeutic agents like checkpoint inhibitors. Its application is particularly focused on improving the efficacy of treatments for various types of cancers, including melanoma, breast cancer, and lung cancer. Research is ongoing to explore its full potential in clinical settings.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :